New Zealand markets close in 1 hour 50 minutes

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
77.29+1.69 (+2.24%)
At close: 04:00PM EDT
77.29 0.00 (0.00%)
After hours: 04:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.15B
Enterprise value 12.50B
Trailing P/E 61.83
Forward P/E 36.63
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.79
Price/book (mrq)6.03
Enterprise value/revenue 10.83
Enterprise value/EBITDA 34.39

Trading information

Stock price history

Beta (5Y monthly) 1.22
52-week change 3-8.11%
S&P500 52-week change 322.38%
52-week high 389.91
52-week low 351.79
50-day moving average 369.68
200-day moving average 370.89

Share statistics

Avg vol (3-month) 31.11M
Avg vol (10-day) 31.42M
Shares outstanding 5157.19M
Implied shares outstanding 6157.19M
Float 8155.51M
% held by insiders 10.97%
% held by institutions 1101.06%
Shares short (15 Apr 2024) 45.75M
Short ratio (15 Apr 2024) 45.68
Short % of float (15 Apr 2024) 44.76%
Short % of shares outstanding (15 Apr 2024) 43.66%
Shares short (prior month 15 Mar 2024) 45.1M

Dividends & splits

Forward annual dividend rate 40.32
Forward annual dividend yield 40.41%
Trailing annual dividend rate 30.08
Trailing annual dividend yield 30.11%
5-year average dividend yield 40.44
Payout ratio 425.60%
Dividend date 324 May 2024
Ex-dividend date 410 May 2024
Last split factor 24:1
Last split date 330 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 17.59%
Operating margin (ttm)22.14%

Management effectiveness

Return on assets (ttm)5.58%
Return on equity (ttm)10.40%

Income statement

Revenue (ttm)1.15B
Revenue per share (ttm)7.32
Quarterly revenue growth (yoy)3.20%
Gross profit (ttm)N/A
EBITDA 303.98M
Net income avi to common (ttm)202.93M
Diluted EPS (ttm)1.25
Quarterly earnings growth (yoy)-30.10%

Balance sheet

Total cash (mrq)145.31M
Total cash per share (mrq)0.92
Total debt (mrq)494.73M
Total debt/equity (mrq)24.56%
Current ratio (mrq)4.08
Book value per share (mrq)12.81

Cash flow statement

Operating cash flow (ttm)306.88M
Levered free cash flow (ttm)178.66M